Robert Steven Davidson - 17 Nov 2016 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: AVRW
Reported as of: 17 Nov 2016
Net transaction value: +$4,439
SEC form: 4
Accepted by SEC: 25 May 2021, 06:01:40 UTC
Next SEC filing: 24 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Robert Davidson

Key filing fact

Robert Steven Davidson filed Form 4 for Cure Pharmaceutical Holding Corp. (AVRW) on 25 May 2021.

Key facts

This page summarizes Robert Steven Davidson's Form 4 filing for Cure Pharmaceutical Holding Corp. (AVRW).
6 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 25 May 2021, 06:01.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$4,439.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVRW transaction

Common Stock

Gift

Transaction value: $0
Shares: -25,000
Change %: -4.5%
Price: $0.000000
Shares after: 524,756
Date: 10 Oct 2018
Ownership: Direct
Footnotes: F1

AVRW transaction

Common Stock

Award

Transaction value: $0
Shares: +31,250
Change %: +6%
Price: $0.000000
Shares after: 556,006
Date: 01 Jul 2019
Ownership: Direct
Footnotes: F2

AVRW transaction

Common Stock

Purchase

Transaction value: $4,439
Shares: +6,443
Change %: +1.2%
Price: $0.6890^*
Shares after: 562,449
Date: 24 May 2021
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVRW transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +354,000
Change %
Price: $0.000000
Shares after: 354,000
Date: 07 Nov 2016
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 354,000
Exercise price: $0.7400
Footnotes: F4

AVRW transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +68,750
Change %
Price: $0.000000
Shares after: 68,750
Date: 07 May 2018
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 68,750
Exercise price: $0.6100
Footnotes: F4

AVRW transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +225,000
Change %
Price: $0.000000
Shares after: 225,000
Date: 11 Apr 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 225,000
Exercise price: $3.40
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reporting person transferred 25,000 shares of common stock to his son as a bona-fide gift. This late filing is due to an inadvertent administrative error and not any error of the reporting person.

Footnote F2

Represents shares of common stock received upon vesting of a restricted stock award. This late filing is due to an inadvertent administrative error and not any error of the reporting person.

Footnote F3

This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.68422 to $0.69350. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 3 decimal points.

Footnote F4

The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.